283 related articles for article (PubMed ID: 28130689)
21. Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer.
Alongi F; Ragusa P; Montemaggi P; Bona CM
Tumori; 2006; 92(4):327-33. PubMed ID: 17036525
[TBL] [Abstract][Full Text] [Related]
22. Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients?
Lee SW; Kim SJ
Clin Nucl Med; 2022 May; 47(5):414-421. PubMed ID: 35234195
[TBL] [Abstract][Full Text] [Related]
23. Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2.
Pahk K; Chung JH; Yi E; Kim S; Lee SH
Eur J Radiol; 2018 Sep; 106():145-149. PubMed ID: 30150037
[TBL] [Abstract][Full Text] [Related]
24. A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes.
Shen H; Chen L; Liu K; Zhao K; Li J; Yu L; Ye H; Zhu W
Quant Imaging Med Surg; 2021 Jul; 11(7):2918-2932. PubMed ID: 34249623
[TBL] [Abstract][Full Text] [Related]
25. Transfer-Learning Deep Radiomics and Hand-Crafted Radiomics for Classifying Lymph Nodes from Contrast-Enhanced Computed Tomography in Lung Cancer.
Laqua FC; Woznicki P; Bley TA; Schöneck M; Rinneburger M; Weisthoff M; Schmidt M; Persigehl T; Iuga AI; Baeßler B
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345187
[TBL] [Abstract][Full Text] [Related]
26. Ratio of Mediastinal Lymph Node SUV to Primary Tumor SUV in
Cho J; Choe JG; Pahk K; Choi S; Kwon HR; Eo JS; Seo HJ; Kim C; Kim S
Nucl Med Mol Imaging; 2017 Jun; 51(2):140-146. PubMed ID: 28559938
[TBL] [Abstract][Full Text] [Related]
27.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
28. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
Huang B; Sollee J; Luo YH; Reddy A; Zhong Z; Wu J; Mammarappallil J; Healey T; Cheng G; Azzoli C; Korogodsky D; Zhang P; Feng X; Li J; Yang L; Jiao Z; Bai HX
EBioMedicine; 2022 Aug; 82():104127. PubMed ID: 35810561
[TBL] [Abstract][Full Text] [Related]
29. Automated lung tumor delineation on positron emission tomography/computed tomography via a hybrid regional network.
Lei Y; Wang T; Jeong JJ; Janopaul-Naylor J; Kesarwala AH; Roper J; Tian S; Bradley JD; Liu T; Higgins K; Yang X
Med Phys; 2023 Jan; 50(1):274-283. PubMed ID: 36203393
[TBL] [Abstract][Full Text] [Related]
30. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
[TBL] [Abstract][Full Text] [Related]
31. Prediction of Lymph Node Maximum Standardized Uptake Value in Patients With Cancer Using a 3D Convolutional Neural Network: A Proof-of-Concept Study.
Shaish H; Mutasa S; Makkar J; Chang P; Schwartz L; Ahmed F
AJR Am J Roentgenol; 2019 Feb; 212(2):238-244. PubMed ID: 30540209
[TBL] [Abstract][Full Text] [Related]
32. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
33. A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers.
Groendahl AR; Skjei Knudtsen I; Huynh BN; Mulstad M; Moe YM; Knuth F; Tomic O; Indahl UG; Torheim T; Dale E; Malinen E; Futsaether CM
Phys Med Biol; 2021 Mar; 66(6):065012. PubMed ID: 33666176
[TBL] [Abstract][Full Text] [Related]
34. Dual-Centre Harmonised Multimodal Positron Emission Tomography/Computed Tomography Image Radiomic Features and Machine Learning Algorithms for Non-small Cell Lung Cancer Histopathological Subtype Phenotype Decoding.
Khodabakhshi Z; Amini M; Hajianfar G; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2023 Nov; 35(11):713-725. PubMed ID: 37599160
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a
Ouyang ML; Wang YR; Deng QS; Zhu YF; Zhao ZH; Wang L; Wang LX; Tang K
Front Oncol; 2021; 11():710909. PubMed ID: 34568038
[TBL] [Abstract][Full Text] [Related]
36. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
Gould MK; Kuschner WG; Rydzak CE; Maclean CC; Demas AN; Shigemitsu H; Chan JK; Owens DK
Ann Intern Med; 2003 Dec; 139(11):879-92. PubMed ID: 14644890
[TBL] [Abstract][Full Text] [Related]
37. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
38. Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists.
Haenssle HA; Fink C; Schneiderbauer R; Toberer F; Buhl T; Blum A; Kalloo A; Hassen ABH; Thomas L; Enk A; Uhlmann L; ; Alt C; Arenbergerova M; Bakos R; Baltzer A; Bertlich I; Blum A; Bokor-Billmann T; Bowling J; Braghiroli N; Braun R; Buder-Bakhaya K; Buhl T; Cabo H; Cabrijan L; Cevic N; Classen A; Deltgen D; Fink C; Georgieva I; Hakim-Meibodi LE; Hanner S; Hartmann F; Hartmann J; Haus G; Hoxha E; Karls R; Koga H; Kreusch J; Lallas A; Majenka P; Marghoob A; Massone C; Mekokishvili L; Mestel D; Meyer V; Neuberger A; Nielsen K; Oliviero M; Pampena R; Paoli J; Pawlik E; Rao B; Rendon A; Russo T; Sadek A; Samhaber K; Schneiderbauer R; Schweizer A; Toberer F; Trennheuser L; Vlahova L; Wald A; Winkler J; Wölbing P; Zalaudek I
Ann Oncol; 2018 Aug; 29(8):1836-1842. PubMed ID: 29846502
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
[TBL] [Abstract][Full Text] [Related]
40. Application of Artificial Neural Network to Preoperative
Taralli S; Scolozzi V; Boldrini L; Lenkowicz J; Pelliccioni A; Lorusso M; Attieh O; Ricciardi S; Carleo F; Cardillo G; Calcagni ML
Front Med (Lausanne); 2021; 8():664529. PubMed ID: 33968968
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
